EUVIMEDEUVIMED entdecken
Kohortenstudie

0447 Cutaneous outcomes following glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: A propensity-matched trinetx cohort study

D. Wambold, O. Alani, L. Shqair, S. Rahman, A. Haque

Journal of Investigative Dermatology · 2026-08 · 146 (8) · S77

DOI: 10.1016/j.jid.2026.06.478 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Investigative Dermatology, 2026-08. Verfasst von D. Wambold und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Wambold, D., Alani, O., Shqair, L., Rahman, S., & Haque, A. (2026). 0447 Cutaneous outcomes following glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: A propensity-matched trinetx cohort study. Journal of Investigative Dermatology, 146(8), S77. https://doi.org/10.1016/j.jid.2026.06.478

Vancouver

Wambold D, Alani O, Shqair L, Rahman S, Haque A. 0447 Cutaneous outcomes following glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: A propensity-matched trinetx cohort study. Journal of Investigative Dermatology. 2026;146(8):S77. doi:10.1016/j.jid.2026.06.478

BibTeX
@article{Wambold2026,
  author = {Wambold, D. and Alani, O. and Shqair, L. and Rahman, S. and Haque, A.},
  title = {0447 Cutaneous outcomes following glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: A propensity-matched trinetx cohort study},
  journal = {Journal of Investigative Dermatology},
  year = {2026},
  volume = {146},
  number = {8},
  pages = {S77},
  doi = {10.1016/j.jid.2026.06.478}
}
Kostenlos starten →